Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin

Anaerobe

Volumn 31, Issue , 2015, Pages 72-77

  Rashid, Mamun Ur ^a   Weintraub, Andrej ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaerobes; Ciprofloxacin; Clindamycin; Human normal microbiota; Long term impact

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; PLACEBO;

ADULT; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; BIFIDOBACTERIACEAE; CONTROLLED STUDY; FECES; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NONHUMAN; NORMAL HUMAN; NOSE; PEPTOCLOSTRIDIUM DIFFICILE; PREVOTELLA; PROPIONIBACTERIUM ACNES; RANDOMIZED CONTROLLED TRIAL; SALIVA; SKIN; VEILLONELLA; DRUG EFFECTS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MICROFLORA; NOSE CAVITY; OROPHARYNX; TIME;

BACTEROIDES SP.; CLOSTRIDIUM DIFFICILE; PREVOTELLA; PROPIONIBACTERIUM ACNES; VEILLONELLA;

BACTERIA, ANAEROBIC; CIPROFLOXACIN; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LONGITUDINAL STUDIES; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIOTA; NASAL CAVITY; OROPHARYNX; PLACEBOS; SKIN; TIME FACTORS;

EID: 84922725696     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.10.004     Document Type: Article

References (30)

1. Evaldson G., Heimdahl A., Kager L., Nord C.E. The normal human anaerobic microflora. Scand J Infect Dis 1982, 35:9-15.
2. Imlay J.A. How oxygen damages microbes: oxygen tolerance and obligate anaerobiosis. Adv Microb Physiol 2002, 46:111-153.
3. Stark C.A., Edlund C., Sjöstedt S., Kristensen G., Nord C.E. Antimicrobial resistance in human oral and intestinal anaerobic microfloras. Antimicrob Agents Chemother 1993, 37:1665-1669.
4. Nagy E., Urban E., Soki J., Terhes G., Nagy K. The place of molecular genetic methods in the diagnostics of human pathogenic anaerobic bacteria. A minireview. Acta Microbiol Immunol Hung 2006, 53:183-194.
5. Tlaskalova-Hogenova H., Stepankova R., Hudcovic T., Tuckova L., Cukrowska B., Lodinova-Zadnikova R., et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004, 93:97-108.
6. Moore S.J., Warren M.J. The anaerobic biosynthesis of vitamin B12. Biochem Soc Trans 2012, 40:581-586.
7. Chapter 1-1. Anaerobic infections (general): epidemiology of anaerobic infections. JInfect Chemother 2011, 17(Suppl.1):4-12.
8. Duncan S.H., Louis P., Flint H.J. Cultivable bacterial diversity from the human colon. Lett Appl Microbiol 2007, 44:343-350.
9. Muller S., Hubschmann T., Kleinsteuber S., Vogt C. High resolution single cell analytics to follow microbial community dynamics in anaerobic ecosystems. Methods 2012, 57:338-349.
10. Sullivan A., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001, 1:101-114.
11. Rashid M.U., Weintraub A., Nord C.E. Effect of new antimicrobial agents on the ecological balance of human microflora. Anaerobe 2012, 18:249-253.
12. LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 1988, 8:3-33.
13. Rashid M., Weintraub A., Nord C.E. Comparative effects of the immediate and the extended release formulations of ciprofloxacin on normal human intestinal microflora. JChemother 2011, 23:145-149.
14. Dang V., Nanda N., Cooper T.W., Greenfield R.A., Bronze M.S. Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins. JOkla State Med Assoc 2007, 100:75-81.
15. Kager L., Liljeqvist L., Malmborg A.S., Nord C.E. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1981, 20:736-740.
16. Brismar B., Edlund C., Malmborg A.S., Nord C.E. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990, 34:481-483.
17. Holt H.A., Lewis D.A., White L.O., Bastable S.Y., Reeves D.S. Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol 1986, 5:201-205.
18. Ljungberg B., Nilsson-Ehle I., Edlund C., Nord C.E. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption. Scand J Infect Dis 1990, 22:205-208.
19. Löfmark S., Jernberg C., Jansson J.K., Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. JAntimicrob Chemother 2006, 58:1160-1167.
20. Oprica C., Emtestam L., Lapins J., Borglund E., Nyberg F., Stenlund K., et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 2004, 10:155-164.
21. Rashid M.U., Dalhoff A., Backstrom T., Bjorkhem-Bergman L., Panagiotidis G., Weintraub A., et al. Ecological impact of MCB3837 on the normal human microbiota. Int J Antimicrob Agents 2014, 44:125-130.
22. Rashid M.U., Panagiotidis G., Backstrom T., Weintraub A., Nord C.E. Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora. Int J Antimicrob Agents 2013, 41:352-357.
23. Nord C.E., Sillerstrom E., Wahlund E. Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother 2006, 50:3375-3380.
24. The European Committee on Antimicribial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1 2013, http://www.eucast.org.
25. Manual of clinical microbiology 2011, ASM Press, Washington, DC. 10th ed. J. Versalovic, K.C. Carroll, G. Funke, J. Jorgensen, M.L. Landry, D.W. Warnock (Eds.).
26. Clinical and Laboratory Standards Institute Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard 2012, CLSI, Wayne, PA, Document M11-A8. 8th ed.
27. Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe 2010, 16:183-189.
28. Stoddart B., Wilcox M.H. Clostridium difficile. Curr Opin Infect Dis 2002, 15:513-518.
29. Talpaert M.J., Gopal Rao G., Cooper B.S., Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. JAntimicrob Chemother 2011, 66:2168-2174.
30. Edlund C., Nord C.E. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. JAntimicrob Chemother 2000, 46:41-48.